The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Renal Insufficiency

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Renal Insufficiency

 

Psychiatry related information on Renal Insufficiency

 

High impact information on Renal Insufficiency

 

Chemical compound and disease context of Renal Insufficiency

 

Biological context of Renal Insufficiency

 

Anatomical context of Renal Insufficiency

 

Gene context of Renal Insufficiency

 

Analytical, diagnostic and therapeutic context of Renal Insufficiency

References

  1. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. Schwab, S.J., Hlatky, M.A., Pieper, K.S., Davidson, C.J., Morris, K.G., Skelton, T.N., Bashore, T.M. N. Engl. J. Med. (1989) [Pubmed]
  2. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. Fernández-del Castillo, C., Harringer, W., Warshaw, A.L., Vlahakes, G.J., Koski, G., Zaslavsky, A.M., Rattner, D.W. N. Engl. J. Med. (1991) [Pubmed]
  3. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J.F., Motolese, M., Ponticelli, C., Ritz, E., Zucchelli, P. N. Engl. J. Med. (1996) [Pubmed]
  4. Relapsing polychondritis with glomerulonephritis. Improvement with prednisone and cyclophosphamide. Ruhlen, J.L., Huston, K.A., Wood, W.G. JAMA (1981) [Pubmed]
  5. Reversible renal failure and myositis caused by phenytoin hypersensitivity. Michael, J.R., Mitch, W.E. JAMA (1976) [Pubmed]
  6. Clonazepam in the treatment of bipolar disorder in patients with non-lithium-induced renal insufficiency. Amiel, M., Bryan, S., Herjanic, M. The Journal of clinical psychiatry. (1987) [Pubmed]
  7. A randomized placebo-controlled double-blind trial of lipid-lowering strategies in patients with renal insufficiency: diet modification with or without fenofibrate. Levin, A., Duncan, L., Djurdjev, O., Shapiro, R.J., Frohlich, J., Belanger, A., Dumas, R., Ross, S. Clin. Nephrol. (2000) [Pubmed]
  8. Megestrol-induced Cushing syndrome. Caparrós, G.C., Zambrana, J.L., Delgado-Fernandez, M., Díez, F. The Annals of pharmacotherapy. (2001) [Pubmed]
  9. Bayesian pharmacokinetics of lithium after an acute self-intoxication and subsequent haemodialysis: a case report. Kerbusch, T., Mathôt, R.A., Otten, H.M., Meesters, E.W., van Kan, H.J., Schellens, J.H., Beijnen, J.H. Pharmacol. Toxicol. (2002) [Pubmed]
  10. What should the role of ACE inhibitors be in the treatment of diabetes? Lessons from HOPE and MICRO-HOPE. Heinig, R.E. Diabetes, obesity & metabolism. (2002) [Pubmed]
  11. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. Moertel, C.G., Lefkopoulo, M., Lipsitz, S., Hahn, R.G., Klaassen, D. N. Engl. J. Med. (1992) [Pubmed]
  12. Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism. Nadler, J.L., Lee, F.O., Hsueh, W., Horton, R. N. Engl. J. Med. (1986) [Pubmed]
  13. Pharmacokinetics of bretylium in renal insufficiency. Adir, J., Narang, P.K., Josselson, J., Sadler, J.H. N. Engl. J. Med. (1979) [Pubmed]
  14. Ototoxicity of erythromycin in patients with renal insufficiency. Méry, J.P., Kanfer, A. N. Engl. J. Med. (1979) [Pubmed]
  15. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R.T., Remotti, H., Stevens, J.L., Ron, D. Genes Dev. (1998) [Pubmed]
  16. Reduction of amphotericin B nephrotoxicity with mannitol. Rosch, J.M., Pazin, G.J., Fireman, P. JAMA (1976) [Pubmed]
  17. Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy. Galler, M., Folkert, V.W., Schlondorff, D. JAMA (1981) [Pubmed]
  18. Forty years of lithium treatment. Schou, M. Arch. Gen. Psychiatry (1997) [Pubmed]
  19. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Radtke, H.W., Claussner, A., Erbes, P.M., Scheuermann, E.H., Schoeppe, W., Koch, K.M. Blood (1979) [Pubmed]
  20. Ibuprofen kinetics in patients with renal insufficiency who are receiving maintenance hemodialysis. Ochs, H.R., Greenblatt, D.J., Verburg-Ochs, B. Arthritis Rheum. (1985) [Pubmed]
  21. Control of hypertension and reversal of renal failure in undifferentiated connective tissue disease by enalapril. Strongwater, S.L., Galvanek, E.G., Stoff, J.S. Arch. Intern. Med. (1989) [Pubmed]
  22. Pregnancy in women with renal disease and moderate renal insufficiency. Hou, S.H., Grossman, S.D., Madias, N.E. Am. J. Med. (1985) [Pubmed]
  23. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture. De Deyn, P.P., Macdonald, R.L. Ann. Neurol. (1990) [Pubmed]
  24. Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians. Nelson, R.G., Wolfe, J.A., Horton, M.B., Pettitt, D.J., Bennett, P.H., Knowler, W.C. Diabetes (1989) [Pubmed]
  25. Quantum proteolytic activation of chemokine CCL15 by neutrophil granulocytes modulates mononuclear cell adhesiveness. Richter, R., Bistrian, R., Escher, S., Forssmann, W.G., Vakili, J., Henschler, R., Spodsberg, N., Frimpong-Boateng, A., Forssmann, U. J. Immunol. (2005) [Pubmed]
  26. Suppression of plasma renin activity by cyclosporine. Bantle, J.P., Boudreau, R.J., Ferris, T.F. Am. J. Med. (1987) [Pubmed]
  27. Rescue of defective branching nephrogenesis in renal-coloboma syndrome by the caspase inhibitor, Z-VAD-fmk. Clark, P., Dziarmaga, A., Eccles, M., Goodyer, P. J. Am. Soc. Nephrol. (2004) [Pubmed]
  28. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects. Meier, J.J., Nauck, M.A., Kranz, D., Holst, J.J., Deacon, C.F., Gaeckler, D., Schmidt, W.E., Gallwitz, B. Diabetes (2004) [Pubmed]
  29. Dyslipoproteinemia in diabetic renal failure. Attman, P.O., Nyberg, G., William-Olsson, T., Knight-Gibson, C., Alaupovic, P. Kidney Int. (1992) [Pubmed]
  30. Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension. Fabris, B., Bortoletto, M., Candido, R., Barbone, F., Cattin, M.R., Calci, M., Scanferla, F., Tizzoni, L., Giacca, M., Carretta, R. J. Hypertens. (2005) [Pubmed]
  31. Mapping of a new candidate locus for uromodulin-associated kidney disease (UAKD) to chromosome 1q41. Hodanová, K., Majewski, J., Kublová, M., Vyletal, P., Kalbácová, M., Stibůrková, B., Hůlková, H., Chagnon, Y.C., Lanouette, C.M., Marinaki, A., Fryns, J.P., Venkat-Raman, G., Kmoch, S. Kidney Int. (2005) [Pubmed]
  32. Genetics and phenotypic characteristics of autosomal dominant polycystic kidney disease in Finns. Peltola, P., Lumiaho, A., Miettinen, R., Pihlajamäki, J., Sandford, R., Laakso, M. J. Mol. Med. (2005) [Pubmed]
  33. Hyperoxaluria and renal insufficiency due to ascorbic acid administration during total parenteral nutrition. Swartz, R.D., Wesley, J.R., Somermeyer, M.G., Lau, K. Ann. Intern. Med. (1984) [Pubmed]
  34. Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation. Rossini, M., Belloni, A., Remuzzi, G., Perico, N. Circulation (1990) [Pubmed]
  35. Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial. Attal, M., Huguet, F., Rubie, H., Charlet, J.P., Schlaifer, D., Huynh, A., Laurent, G., Pris, J. Blood (1993) [Pubmed]
  36. Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. Branten, A.J., du Buf-Vereijken, P.W., Klasen, I.S., Bosch, F.H., Feith, G.W., Hollander, D.A., Wetzels, J.F. J. Am. Soc. Nephrol. (2005) [Pubmed]
  37. Pancreatic exocrine function in severe human chronic renal failure. Owyang, C., Miller, L.J., DiMagno, E.P., Mitchell, J.C., Go, V.L. Gut (1982) [Pubmed]
 
WikiGenes - Universities